INS and type 2 diabetes mellitus: The reporting of cardiovascular complications for the comparison of combining metformin with insulin compared with insulin monotherapy in people with type 2 diabetes was infrequent, and when meta-analyses could be performed, the data were sparse and effect estimates were non-significant [7].